Table 2. Prevalence of IPC after TURP.
| Variable | Total | BPH | IPC | p-value | |
|---|---|---|---|---|---|
| Biopsy methods | 0.47 | ||||
| Transperineal MRI/TRUS fusion prostate biopsy | 50 | 49 | 1 | ||
| TRUS-guided prostate biopsy | 203 | 192 | 11 | ||
| MRI findings | 0.50 | ||||
| Suspicious | 145 | 137 | 8 | ||
| Non-suspicious | 72 | 70 | 2 | ||
| DRE findings | 0.44 | ||||
| Suspicious | 43 | 40 | 3 | ||
| Non-suspicious | 210 | 201 | 9 | ||
Values are presented as number only.
IPC, incidental prostate cancer; TURP, transurethral resection of the prostate; BPH, benign prostatic hyperplasia; MRI, magnetic resonance imaging; TRUS, transrectal ultrasonography; DRE, digital rectal examination.
A p-value of <0.05 was considered statistically significant.